FORT LAUDERDALE, Fla., April 17, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, soon to be changed from Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today that the company is in negotiations with two new supply chain distributors for its signature supplement product Azul Instant.
Nouveau Life Pharmaceuticals is currently engaged in discussions with two supply chain vendors for distribution services. Combined, these two vendors supply upwards of 50% of distribution networks for nutraceuticals and all-natural supplements. The addition of these two well-established distributors would allow Nouveau Life to streamline operations, increase profit margins, and minimize time-to-market while enabling the company to fulfill current distribution agreements and meet growing consumer demand.
“Nouveau Life will never pass up an opportunity to keep quality of product at the forefront while increasing ROI,” said CEO Ramiro Cadena.
Furthermore, an arrangement with the two distribution firms could lower costs in other areas of the product-to-market process. Nouveau Life anticipates ancillary savings in all stages of the supply chain from production to marketing to fulfillment by capitalizing on the long-standing industry relationships these two distributors have to offer.
About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements - This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.
CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.
